European Journal of Epidemiology

, Volume 19, Issue 12, pp 1089–1095 | Cite as

Risk of low-energy hip, wrist, and upper arm fractures among current and previous users of hormone replacement therapy: The Danish Nurse Cohort Study

  • Yrsa Andersen Hundrup
  • Susanne Høidrup
  • Ola Ekholm
  • Michael Davidsen
  • Erik Bernhard Obel
Locomotor Epidemiology

Abstract

Objective: To examine the effect of oestrogen alone and in combination with progestin on the risk of low-energy, hip, wrist, and upper arm fractures. Additionally, to examine to what extent previous use, duration of use as well as recency of discontinuation of hormone replacement therapy (HRT) influences the fracture risk. Design: Prospective cohort study. Setting: The Danish Nurse Cohort Study Participants: 7082 female nurses aged 50–69, who completed a questionnaire on lifestyle and use of HRT in 1993. Outcome measures: Self-reported low-energy, hip, wrist, and upper arm fractures between 1993–1999 obtained at a re-examination in 1999. Results: Compared to never users, current users of HRT, either oestrogen alone or combined with progestin, had a lower risk of low-energy, hip, wrist, and upper arm fractures (hazard ratio 0.60, 0.39–0.93 and hazard ratio 0.44, 0.30–0.66, respectively). The protective effect of HRT appeared to be significantly restricted to users who used the therapy for 10 years or more (hazard ratio 0.27, 0.14–0.51). Women who previously used hormones experienced no protective effect on fracture risk regardless of duration of therapy and recency of discontinuation. Conclusion: Only long-term HRT (10 years or more) offers a protective effect against low energy, hip, wrist, and upper arm fractures. In women with risk factors or established osteoporosis, benefits and risks of this therapy should be balanced when considering its use as a first line treatment for prevention of these fractures.

Keywords

Hormone replacement therapy Low-energy fractures Osteoporosis Prospective cohort study 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Nilas, L, Christiansen, C 1987Bone mass and its relationship to age and the menopauseJ Clin Endocrinol Metab65697702PubMedCrossRefGoogle Scholar
  2. Kanis, JA. 1993The incidence of hip fracture in EuropeOsteoporosis IntSuppl. 11015CrossRefGoogle Scholar
  3. Christiansen, C, Christensen, MS, McNair, P, Hagen, C, Stocklund, K-E, Transb¢l, I 1980Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.Eur J Clin Invest10273279PubMedCrossRefGoogle Scholar
  4. Eiken, P, Kolthoff, N, Nielsen, NS 1996Effect of 10 year’s hormone replacement therapy on bone mineral content in postmenopausal womenBone19191S193SCrossRefPubMedGoogle Scholar
  5. The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on bone mineral density. Results from the postmenopausal oestrogen/progestin interventions (PEPI) trial. JAMA 1996; 276: 1389–1396.Google Scholar
  6. Grady, D, Rubin, SM, Petitti, DB, Fox, CS, Black, D, Ettinger, B,  et al. 1992Hormone therapy to prevent disease and prolong life in postmenopausal womenAnn Intern Med11710161036PubMedGoogle Scholar
  7. Maxim, P, Ettinger, B, Spitalny, GM 1995Fracture protection provided by long-term estrogen treatmentOsteoporos Int52329CrossRefPubMedGoogle Scholar
  8. Høidrup, S, Gr¢nbæk, M, Pedersen, AT, Lauritzen, JB, Gottschau, A, Schroll, M 1999Hormone replacement therapy and hip fracture risk–the effect modification by tobacco smoking, alcohol intake, physical activity and body mass indexAm J Epidemiol15010851093PubMedGoogle Scholar
  9. Cauley, JA, Seeley, DG, Ensrud, K, Ettinger, B, Black, D, Cummings, SR 1995Estrogen replacement therapy and fractures in older womenAnn. Intern. Med122916PubMedGoogle Scholar
  10. Grodstein, F, Stampfer, MJ, Falkeborn, M, Naessén, T, Persson, I 1999Postmenopausal hormone therapy and risk of cardiovascular disease and hip fracture in a cohort of Swedish womenEpidemiology10476480PubMedCrossRefGoogle Scholar
  11. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative. Randomized controlled trial. JAMA 2002; 288: 321–333.Google Scholar
  12. Michaëlsson, K, Baron, JA, Farahmand, BY, Johnell, O, Magnusson, C, Persson, P-G,  et al. 1998Hormone replacement therapy and risk of hip fracture: population based case–control studyBr Med J31618581863Google Scholar
  13. Johnell, O, Gullberg, B, Kanis, JA, Allander, E, Elfors, A, Dequeker, J,  et al. 1995Risk factors for hip fracture in European women: The MEDOS StudyJ. Bone Miner Res1018021815PubMedCrossRefGoogle Scholar
  14. Cummings, SR, Nevitt, MC, Browner, WS, Stone, K, Fox, CS, Ensrud, K,  et al. 1995Risk factors for hip fracture in white womenN Engl J Med332767773CrossRefPubMedGoogle Scholar
  15. NOMESKO. Nordisk Ulykkesklassifikation. 8. 1987.Google Scholar
  16. Torgerson, DJ, Bell-Syser, SEM 2001Hormone Replacement Therapy and prevention of nonvertebral fractures–A metaanalysis of randomized trialsJAMA28528912897CrossRefPubMedGoogle Scholar
  17. Weiss, NS, Ure, CL, Ballard, JH, Williams Ann, R, Daling, JR 1980Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogenN Engl J Med30311951198PubMedCrossRefGoogle Scholar
  18. Kiel, DP, Felson, DT, Anderson, JJ, Wilson, PWF, Moskowitz, MA 1987Hip fracture and the use of estrogen in␣postmenopausal women. The Framingham studyN␣Engl J Med31711691174PubMedCrossRefGoogle Scholar
  19. Schneider, DL, Barrett-Connor, EL, Morton, DJ 1997Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernado Study.JAMA277543547PubMedCrossRefGoogle Scholar
  20. Løkkegaard, E, Johnsen, SP, Heitmann, BL, Stahlberg, C, Pedersen, AT, Obel, EB,  et al. 2004The validity of self-reported use of hormone replacement therapy among Danish nursesActa Obstet Gynecol Scand83476481PubMedCrossRefGoogle Scholar
  21. Hundrup, YA, Obel, EB, Rasmussen, NK, Philip, J 2000Use of hormone replacement therapy among Danish nurses in 1993Acta Obstet Gynecol Scand79194201PubMedCrossRefGoogle Scholar
  22. Hundrup, YA, Høidrup, S, Obel, EB 2004The validity of self-reported fractures among Danish nurses: A comparison with fractures registered in the Danish National Hospital registerScand J Public Health32136143CrossRefPubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers 2004

Authors and Affiliations

  • Yrsa Andersen Hundrup
    • 1
  • Susanne Høidrup
    • 2
  • Ola Ekholm
    • 1
  • Michael Davidsen
    • 1
  • Erik Bernhard Obel
    • 1
  1. 1.The Danish Nurse Cohort StudyNational Institute of Public HealthCopenhagenDenmark
  2. 2.Research Unit for Dietary StudiesInstitute of Preventive MedicineCopenhagenDenmark

Personalised recommendations